GlassScriptPhysician profile
Amanda Mae Selchau
NPI 1487009635
$1,592.25
in general payments reported to CMS, 2019-2025
9 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $209 · 2022: $101 · 2023: $30.45 · 2024: $133 · 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $829.43 | 2020-2025 | Idosetr, Istent Infinite, Kxl System (Not Refurbished) |
| Alcon Vision LLC | $211.59 | 2020-2025 | Clareon |
| Johnson & Johnson Surgical Vision, INC. | $180.54 | 2024-2025 | Amo Phaco Needle, Tecnis Iol, Veritas Vision System |
| Rxsight INC | $120.12 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Allergan, INC. | $101.36 | 2022 | |
| Abbvie INC. | $49.92 | 2025 | |
| Dompe US, INC. | $46.44 | 2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $36.59 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $16.26 | 2024 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Selchau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.